BLUE Pacific Act

HR842 — Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Would expand Medicare to cover multi-cancer early detection screening tests. It defines eligible tests as certain FDA-cleared or approved genomic blood tests or comparable biological-sample tests and directs the Secretary to use the national coverage determinations process to decide when they are covered.

HR2102 — Major Richard Star Act

Establishes concurrent receipt for retirees with combat-related disabilities. This bill would let eligible retirees receive both military retired pay and veterans' disability compensation for the same months without the offset rules that currently reduce payments. - Families of disabled retirees: Veterans with combat-related disabilities would receive both retired pay and VA disability compensation for the same months, increasing their monthly household income. - Defense and VA payment rules: The bill would amend 10 U.S.C. 1413a and 10 U.S.C. 1414 to exempt retired pay from reductions under 38 U.S.C. 5304 and 5305 and add a clear monthly no-offset rule. - Implementation and technical changes: It renames and updates chapter sections, adjusts cross-references, and applies to payments beginning the first month after enactment.

HR1262 — Mikaela Naylon Give Kids a Chance Act

Speeds and strengthens pediatric cancer drug development. It expands which cancer products companies must study in children, reshapes organ transplant network governance and fees, and adds new FDA international and transparency steps. - Children with cancer and researchers: Requires pediatric studies that produce clinically meaningful data on dosing, safety, and early effectiveness and widens the kinds of drug combinations studied. It also sets aside $25 million for pediatric drug studies in each of fiscal years 2026, 2027, and 2028. - Transplant patients and transplant network members: Changes Organ Procurement and Transplantation Network governance and financing by allowing quarterly registration fees, requiring those fees fund OPTN operations, improving electronic health record integration, and calling for a GAO review within two years. - FDA partners and drug makers: Creates an Abraham Accords Office to boost regulatory coordination and technical assistance abroad, and forces more transparency during generic (ANDA) reviews about whether generics are qualitatively and quantitatively the same as listed drugs. It also raises the Medicare Improvement Fund amount from $1.4 billion to $2.6 billion. Increases federal outlays by roughly $1.3 billion, driven by a $1.2 billion boost to the Medicare Improvement Fund and $75 million for pediatric studies, adding to federal spending.

HR3332 — Pacific Partnership Act

A coordinated U.S. strategy to guide diplomacy, security, and economic engagement across the Pacific Islands region. This bill would require a formal Strategy for Pacific Partnership and set rules for consultation, coordination, and reporting to address disasters, fisheries, and transnational crime. - For Pacific Island governments, regional organizations, and civil society: would create formal consultative processes to align programming, avoid exceeding absorptive capacity, and support a shared regional development vision. - For the U.S. government and Congress: would require the President, with the Secretary of State, to submit a Strategy for Pacific Partnership by Jan 1, 2026 and again by Jan 1, 2030 that lists goals, threat assessments, response plans, resource needs, and coordination mechanisms. - For regional forums and reporting agencies: would extend immunities to the Pacific Islands Forum under the International Organizations Immunities Act and require annual updates to reports on transnational crime, fisheries management, and trafficking in persons with a Pacific regional focus.

HR1422 — Enhanced Iran Sanctions Act of 2025

Targets Iran's energy revenue through global sanctions. This bill would create a broad sanctions framework to punish foreign persons who process, export, or sell Iran-origin oil, condensates, gas, LNG, or petrochemical products. It pairs blocking of assets and visa bans with ownership-based triggers, waivers, humanitarian carve-outs, and new reporting to limit Iran's access to energy markets and finance for weapons and terrorism. - Foreign energy firms and financial institutions would face blocking of property and bans on transactions if they knowingly handle Iran-origin energy or are 50% or more owned by such actors. Associated aliens could become inadmissible and have visas revoked. - Maritime operators, insurers, flag registries, and LNG pipeline facilities would be exposed to sanctions risk when linked to Iran-origin shipments, though safety-of-crew rules and specific exemptions for imports remain. - Humanitarian organizations would keep explicit exemptions for agricultural commodities, food, medicine, medical devices, and humanitarian assistance to avoid disrupting aid. - U.S. agencies and private companies would see new duties: an interagency working group and multilateral contact group would coordinate enforcement, and private-sector reporting would be required to flag evasion and proceeds from intercepted Iran-origin energy sales.

HR3514 — Improving Seniors’ Timely Access to Care Act of 2025

Standardize prior authorization in Medicare Advantage plans to make approvals faster and more transparent for beneficiaries and providers. The bill would require plans that use prior authorization to adopt a secure electronic PA program, publish plan-level PA data, and follow federal timeframes and enrollee protections.